SEC Filing Summary for Philip P. Boudreau

Philip P. Boudreau, EVP and CFO of ABBOTT LABORATORIES (ABT), reported a series of transactions on April 23, 2026. Boudreau acquired 8,909 common shares without par value through the Abbott Laboratories Stock Retirement Trust for a price of $92.04 per share, resulting in 9,276 shares held in the trust. Additionally, Boudreau acquired 2,200 common shares without par value by spouse for a price of $91.50 per share, holding 2,200 shares. Following these transactions, Boudreau directly owns 71,172 common shares. The reporting owner signed the document on April 27, 2026, through an attorney-in-fact.